The quinazolinone sulfonylcarbamate L-163,579 (9) is a potent, balanced antagonist of the binding of angiotensin II (Ang II) to human AT(1) and AT(2) receptors. This antagonist produces a long-lasting blockade of Ang II-induced presser response in both rats and dogs after oral administration.